The GLP-1 and GIP components function similarly to tirzepatide, providing appetite suppression, improved insulin dynamics, and reduced caloric intake
However, the innovations of GLP-1s meant they could mimic the hormone GLP-1 and be resistant to the DPP4 enzyme, so they had a lasting impact on blood sugar levels and appetite
Many people begin this journey because they want to feel healthier, move with less discomfort, or reclaim confidence after years of frustration
You may be able to think clearer and with better recall as pain symptoms reduce
A common misconception about GLP-1 receptor agonists is that they require daily dosing like many other medications
This long-chain peptide functions as a triple receptor agonist, targeting glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors in experimental systems